stockrow
Saturday 31 October 2026
Export OHI’s income statement to Excel — free account
Omega Healthcare Investors, Inc.
OHI Real Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.
46.98
0.14
+0.30%
Follow OHI
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.33 | 22.74 | 21.07 | 16.85 |
P/S ratio |
10.86 | 10.87 | 10.53 | 11.11 | |
P/FCF ratio |
80.73 | 159.52 | 184.85 | 17.12 | |
P/Operating CF |
55.09 | 56.07 | 60.40 | 65.45 | |
P/B ratio |
2.38 | 2.38 | 2.39 | 2.53 | |
Price to Tangible BV |
2.72 | 2.70 | 2.71 | 2.85 | |
EV/Sales |
14.53 | 11.02 | 14.08 | 10.98 | |
EV/EBITDA |
16.37 | 12.57 | 15.81 | 12.45 | |
EV/Operating CF |
19.06 | 14.93 | 19.08 | 15.80 | |
EV/FCF |
108.00 | 161.84 | 247.17 | 16.91 | |
Quick Ratio |
3.15 | 1.89 | 1.21 | 2.10 | |
Current Ratio |
7.11 | 5.81 | 5.32 | 6.03 | |
Net Debt/EBITDA |
14.67 | 0.68 | 15.68 | (0.62) | |
Debt/Assets |
47.14% | 2.41% | 43.40% | 0.06% | |
Debt/Equity |
0.95 | 0.04 | 0.81 | 0.00 | |
Asset Turnover |
0.11 | 0.12 | 0.12 | 0.12 | |
Operating CF/Net income |
1.24 | 1.35 | 1.54 | 0.58 | |
Capex/Depreciation |
(0.11) | (4.34) | (1.85) | 4.44 | |
Interest Coverage |
3.52 | 3.78 | 4.13 | 3.92 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.63% | 7.83% | 8.06% | 12.79% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
2.98% | 3.09% | 3.28% | 7.14% | |
Graham Net Nets |
(0.22) | (0.20) | (0.23) | (0.16) | |
Graham Number |
26.87 | 28.61 | 29.32 | 34.67 | |
Earnings Yield |
4.29% | 4.40% | 4.75% | 5.94% | |
Free Cash Flow Yield |
1.24% | 0.63% | 0.54% | 5.84% | |
Revenue per Share |
1.05 | 1.09 | 1.09 | 1.10 | |
Operating CF per Share |
0.77 | 0.79 | 0.73 | 0.73 | |
Capex per Share |
(0.03) | (1.19) | (0.46) | 1.46 | |
Free Cash Flow per Share |
0.73 | (0.40) | 0.26 | 2.19 | |
Cash per Share |
2.62 | 0.19 | 0.18 | 0.62 | |
Shareholders Equity per Share |
17.73 | 18.65 | 18.36 | 18.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
17.73 | 18.65 | 18.36 | 18.88 | |
Free Cash Flow |
217.38 | (117.43) | 77.69 | 654.61 | |
Working Capital |
2,185.08 | 1,694.06 | 1,459.70 | 1,749.35 | |
Capital Expenditures |
(9.34) | (348.05) | (137.82) | 436.89 | |
Net Current Asset Value |
(2,809.46) | (2,561.95) | (2,981.59) | (2,275.26) | |
EV/EBIT |
24.06 | 18.29 | 22.63 | 17.72 | |
Capex to Sales |
0.03 | 1.09 | 0.43 | (1.33) | |
Price to Operating Income |
17.99 | 18.03 | 16.93 | 17.94 | |
| Other line items | |||||
Average Receivables |
349.15 | 477.99 | 349.32 | 445.58 | |
Average Assets |
10,083.94 | 9,973.48 | 9,970.14 | 10,280.62 | |
Average Common Equity |
4,822.18 | 5,085.67 | 5,193.52 | 5,415.65 |
Columns are period end dates · fundamentals updated 25 Oct 2026